All the sequence data is available from the DRA database (accession number DRA002504).

Introduction {#sec001}
============

The pathogenic epsilon-proteobacterium *Helicobacter pylori* is a major cause of human gastric diseases \[[@pone.0127197.ref001]\]. The *H*. *pylori* genome sequence exhibits a high degree of diversity even between closely related strains because of the high rate of mutation and recombination \[[@pone.0127197.ref002]--[@pone.0127197.ref006]\]. The epigenome is also diverse owing to changes in methyltransferase genes through various mechanisms \[[@pone.0127197.ref007]--[@pone.0127197.ref012]\].

The significance of such extreme genome/epigenome diversity is not understood in detail, although the ability to adapt to the human host has been often suggested. Evidence for effects of DNA modification on gene transcription in bacteria has been limited primarily because of lack of techniques to sensitively and accurately detect methylated DNA bases and to accurately measure transcripts. The Single-Molecule Real-Time (SMRT) sequencing technology now allows methylome decoding at the single base resolution \[[@pone.0127197.ref013], [@pone.0127197.ref014]\]. On the other hand, RNA-seq method in the next-generation sequencers allows accurate and sensitive measurements of transcriptome changes \[[@pone.0127197.ref015]\]. As a result, there are now an increasing number of reports on relationship between DNA methylation by modification enzymes and transcriptome in bacteria. For example, Type II restriction-modification (RM) systems affect global gene expression in *Escherichia coli* \[[@pone.0127197.ref016]\] and in *H*. *pylori* \[[@pone.0127197.ref017]\]. Type III restriction-modification systems affect expression of various genes in *Neisseria*, *Haemophilus* and *H*. *pylori* \[[@pone.0127197.ref010], [@pone.0127197.ref018], [@pone.0127197.ref019]\]. Type I restriction-modification systems affect gene expression in *H*. *pylori* \[[@pone.0127197.ref007]\] and *Streptococcus pneumoniae* \[[@pone.0127197.ref020]\]. There is also evidence that Type II modification enzymes affect *H*. *pylori* physiology \[[@pone.0127197.ref021]--[@pone.0127197.ref023]\].

There have been many studies of human familial transmission in attempts to identify transmission pathways. Early studies used electrophoresis-based methods or multi-locus sequence typing (MLST) based on seven conserved genes (\~3 kb in total) \[[@pone.0127197.ref024], [@pone.0127197.ref025]\]. Recently, more sensitive whole genome (\~1.6 Mb) sequencing was used to analyze the process of familial infection \[[@pone.0127197.ref026]--[@pone.0127197.ref028]\].

In order to gain insight into *H*. *pylori* adaptive evolution in a new human host, especially in a child who was supposed to be newly infected, we used whole genome sequencing of very closely related *H*. *pylori* strains from the same family, which are difficult to distinguish by standard MLST analysis \[[@pone.0127197.ref029]\] and estimated the order of intrafamilial infection and then investigated which genes have experienced amino acid changes.

Results {#sec002}
=======

Families infected with *H*. *pylori* of the same or very similar MLST sequence type {#sec003}
-----------------------------------------------------------------------------------

In all, 19 *H*. *pylori* strains were isolated from five families (one strain per person) visiting a pediatrician in a hospital in Hokkaido, Japan (**[Table 1](#pone.0127197.t001){ref-type="table"}**). Each family member was infected with *H*. *pylori* strains of the same or very similar sequence type as judged by standard MLST analysis (**[S1 Table](#pone.0127197.s001){ref-type="supplementary-material"}**): the mother and the offspring in families K-1 and K-2, the parents and offspring in families K-3 and K-4, and the children in family K-5 \[[@pone.0127197.ref029]\]. The likely direction of familial transmission in families K-1 and K-2 was from mother to offspring. The allele type numbers of some of the seven MLST genes were different in families K-3 and K-4; this is based on a single nucleotide substitution, however, so we regard them as very similar sequences. The MLST results did not make it clear whether the father or the mother was the *H*. *pylori* donor to the offspring. In family K-5, transmission was likely from outside the family, which might be independent among children from the same reservoir or might have been followed by inter-child transmission.

10.1371/journal.pone.0127197.t001

###### Strains and mapping results.
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  Family   Strain[^a^](#t001fn001){ref-type="table-fn"}   Relationship   Age   Mapped nt (\> x5)   Mapped %   Variation \#[^b^](#t001fn002){ref-type="table-fn"}
  -------- ---------------------------------------------- -------------- ----- ------------------- ---------- ----------------------------------------------------
  K-1      K16                                            Father         39    1456954             92.8       35242
           **K17**                                        Mother         38    1456823             92.8       34456
           **K15**                                        Child          10    1457425             92.8       34540
  K-2      K34                                            Father         51    1459303             92.9       35271
           **K35**                                        Mother         46    1419326             90.4       37269
           **K36**                                        Child          17    1419365             90.4       37305
           **K37**                                        Child          14    1419197             90.4       37288
  K-3      **K26**                                        Father         43    1459932             93.0       35041
           **K27**                                        Mother         28    1460893             93.0       34981
           **K28**                                        Child          6     1458283             92.9       34968
  K-4      **K29**                                        Father         48    1379964             87.9       37440
           **K30**                                        Mother         44    1378891             87.8       37389
           **K32**                                        Child          14    1377440             87.7       37387
           **K33**                                        Child          13    1378456             87.8       37422
  K-5      K21                                            Father         46    1462911             93.1       35064
           K22                                            Mother         47    1452079             92.5       34581
           **K23**                                        Child          17    1455829             92.7       33890
           **K24**                                        Child          15    1457747             92.8       33882
           **K25**                                        Child          5     1457010             92.8       33823

a Strains with same sequence type within a family are underlined.

b Number of variations compared with F30 genome.

All these strains were shotgun sequenced by an Illumina high-throughput sequencer and mapped onto the known genome sequence of *H*. *pylori* strain F30 (**[Table 1](#pone.0127197.t001){ref-type="table"}**), which belongs to the hspEAsia population (as do most isolates in Japan) \[[@pone.0127197.ref004], [@pone.0127197.ref030]\]. About 90% of nucleotides were mapped with coverage of more than five reads, with detection of \~35,000 nucleotide substitutions per strain. A lower mapping rate in the strains found in family K-4 can be explained by the lack of a cag pathogenicity island in their genomes. Little difference was observed when other hspEAsia genomes (F16, F32 and F57) \[[@pone.0127197.ref004]\] were used as a reference genome for mapping (**[S2 Table](#pone.0127197.s002){ref-type="supplementary-material"}**), so we used the mapping on *H*. *pylori* strain F30 for further analysis.

Estimation of transmission pathways from the number of nucleotide substitutions {#sec004}
-------------------------------------------------------------------------------

Nucleotide substitutions between each strain pair within a family were counted and used as the distance between compared strains (**[S3 Table](#pone.0127197.s003){ref-type="supplementary-material"}**) to construct a phylogenetic tree for each family (**[Fig 1](#pone.0127197.g001){ref-type="fig"}**). As expected, the number of nucleotide substitutions between strains of distantly related MLST sequence types was greater compared to the same or very similar MLST sequence type by one to three orders of magnitude. From the whole genome sequence information, various evolutionary relations were inferred between multiple strains of the same or very similar MLST sequence type within a family.

![Phylogenetic trees of *H*. *pylori* genomes in the families.\
The number of nucleotide substitutions was used as the distance matrix. The relation and age of the host is added next to the strain name. (A) Family K-1. (B)(i) Family K-2. (ii) Strains with the same MLST sequence type in Family K-2. (C) Family K-3. (D) Family K-4. (E)(i) Family K-5. (ii) Strains with the same MLST sequence type in Family K-5. The bar indicates the number of nucleotide substitutions.](pone.0127197.g001){#pone.0127197.g001}

In family K-2, comparison of three strains with the same MLST sequence type showed the distance between the two strains from children K36 and K37 was, on average, 1.7-fold smaller compared to K35 (from mother) and K36 (from child) and to K35 (from mother) and K37 (from child) (**[Fig 1B](#pone.0127197.g001){ref-type="fig"} (ii)**). The difference was statistically significant (*P* \< 10^--5^), supporting the hypothesis that the latest infection (transfer) occurred between the hosts of K36 and K37; i.e. transmission between children. (This inference is discussed in Discussion, below.)

A comparison of three strains with the same MLST sequence type in family K-3 showed the distance between K27 (from mother) and K28 (from child) is about half compared to K26 (from father) and K27 (from mother) and to K26 (from father) and K28 (from child) (**[Fig 1C](#pone.0127197.g001){ref-type="fig"}**). The difference is significantly greater compared to assuming a random distribution of substitution mutations (*P* \< 10^--5^), suggesting the latest infection occurred between the hosts of K27 (mother) and K28 (child); i.e. transmission between mother and child. The likely direction is from mother to child, considering the general pathway of *H*. *pylori* infection. (See [Discussion](#sec011){ref-type="sec"}, below.)

No significant difference between distances was found for the four strains of very similar MLST sequence type in family K-4 (P \> 0.01, **[Fig 1D](#pone.0127197.g001){ref-type="fig"}**).

There were three MLST sequence types corresponding to father, mother and offspring in family K-5 (see the preceding section). No significant difference between distances was detected for the three strains isolated from the offspring (P \> 0.01, **[Fig 1E](#pone.0127197.g001){ref-type="fig"} (ii)**).

Detection and classification of strain-specific nucleotide substitutions {#sec005}
------------------------------------------------------------------------

All the nucleotide variations in strains with the same or very similar MLST sequence type were compared within each family for the detection of strain-specific nucleotide substitutions. Bases corresponding to the same site were compared, and assigned as a strain-specific substitution when only a single strain had a base different from the other strains in the comparison. In the case of family K-1, there were only two strains with the same sequence type, so we could not distinguish K15-specific from K17-specific substitutions and treated all the substitutions as strain-specific mutations.

We classified base substitutions to single nucleotide variations (SNVs) or clusters of nucleotide polymorphisms (CNPs) in order to estimate the frequency of recombination (**[Table 2](#pone.0127197.t002){ref-type="table"}**). CNP is defined as a cluster of two or more substitutions separated by \<200 bp and flanked by \>200 bp of identical sequence on both sides and is considered as a sign of substitution by a recombination event \[[@pone.0127197.ref031]\]. Substitutions not clustered as CNPs were assigned as SNVs. A large number of CNPs was observed in family K-1, which accounted for about 85% of substitutions. The number of substitutions included in a CNP was, on average, about 11 for those of family K-1 but less than three in all the other strains.

10.1371/journal.pone.0127197.t002

###### Strain specific nucleotide substitutions.
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                                                                                                                         Strain specific            Substitution   non-synonymous/   
  ----- ------------------------------------------------- ------------------ ------------------------------------------- ----------------- -------- -------------- ----------------- ---------------
  K-1   K17 & K15[^b^](#t002fn002){ref-type="table-fn"}   Mother and Child   N/A[^c^](#t002fn003){ref-type="table-fn"}   1213              183/95   10.8           437/695/83        N/A
  K-2   K35                                               Mother             46                                          182               154/12   2.3            96/62/24          N/A
        K36                                               Child              17                                          83                69/7     2.0            50/22/11          2.6 x 10^--6^
        K37                                               Child              14                                          71                54/7     2.4            40/20/11          2.5 x 10^--6^
  K-3   K26                                               Father             43                                          291               214/27   2.9            186/64/41         N/A
        K27                                               Mother             28                                          87                74/6     2.2            46/24/17          N/A
        K28                                               Child              6                                           103               80/8     2.9            49/34/20          5.2 x 10^--6^
  K-4   K29                                               Father             48                                          69                64/2     2.5            39/20/10          N/A
        K30                                               Mother             44                                          78                74/2     2.0            41/28/7           N/A
        K32                                               Child              14                                          110               89/8     2.6            77/20/33          4.0 x 10^--6^
        K33                                               Child              13                                          97                78/9     2.1            68/23/6           3.8 x 10^--6^
  K-5   K23                                               Child              17                                          50                37/6     2.2            19/13/18          1.3 x 10^--6^
        K24                                               Child              15                                          17                17/0     N/A            12/4/1            0.7 x 10^--6^
        K25                                               Child              5                                           46                30/6     2.7            25/10/11          3.8 x 10^--6^

a Rate of SNV per site per year.

b K15 and K17 were counted together because we cannot assign strain specific substitutions by comparison of two strains.

c N/A, not applicable.

Strain-specific nucleotide substitutions were classified into nonsynonymous (changing amino acid), synonymous (retaining amino acid) and substitutions in noncoding regions. The mutation rate was calculated for isolates from children by dividing the number of SNVs (substitutions not included in CNPs) by their age in years, assuming *H*. *pylori* infection occurred soon after birth. The rate ranged from 0.7 x 10^--6^--5.2 x 10^--6^ per year per site (**[S4 Table](#pone.0127197.s004){ref-type="supplementary-material"}**). The value is comparable to those reported for earlier estimations for intra-family evolution \[[@pone.0127197.ref026], [@pone.0127197.ref031], [@pone.0127197.ref032]\].

Genes with an amino acid substitution {#sec006}
-------------------------------------

We investigated which genes had experienced an amino acid substitution using function-based gene grouping with clusters of orthologous groups (COG) \[[@pone.0127197.ref033]\] (**[Table 3](#pone.0127197.t003){ref-type="table"}, [S5 Table](#pone.0127197.s005){ref-type="supplementary-material"}**). The number of genes with at least one nonsynonymous substitution was counted. We found enrichment of amino acid substitutions in COG categories of M (cell wall/membrane/envelope biogenesis) and T (signal transduction) genes in multiple strains. The category M genes included those for outer membrane proteins (OMPs), lipopolysaccharide biosynthesis, lipoprotein-related proteins, penicillin-binding proteins in the cell wall and cell division proteins (**[S6 Table](#pone.0127197.s006){ref-type="supplementary-material"}**). Category T genes included *spoT* (included also in category K) and chemotaxis-related genes (included also in category N) (**[S6 Table](#pone.0127197.s006){ref-type="supplementary-material"}**). The genes with nonsynonymous substitutions included those decayed in hspEastAsia, including molybdenum-related genes (*mogA* and *modB*), and those decayed in hpEurope, including *ackA* for acetate formation \[[@pone.0127197.ref004]\]. The substitution mutations might represent a step in their decay.

10.1371/journal.pone.0127197.t003

###### COG enrichment of genes with strain specific non-synonymous substitutions.
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                                                         K-1                                       K-2                                       K-3                                      K-4   K-5                                                                                                                                                                                                                               
  ----- ----------------------------------------- ------ ----------------------------------------- ----------------------------------------- ---------------------------------------- ----- ----------------------------------------- ---- ---------------------------------------- ---- ---------------------------------------- ---------------------------------------- ---------------------------------------- ---- ---- ----------------------------------------
  C     Energy production and conversion          75     8                                         2                                         1                                        3     2                                         1    2                                        1    1                                        3                                        0                                        0    0    2
  D     Cell cycle control and mitosis            20     0                                         2                                         1                                        1     1                                         0    0                                        1    0                                        0                                        1                                        0    0    0
  E     Amino Acid metabolism and transport       97     9                                         3                                         2                                        0     7                                         4    2                                        3    6                                        1                                        2                                        0    0    0
  F     Nucleotide metabolism and transport       39     3                                         1                                         2                                        1     1                                         0    0                                        1    0                                        2                                        0                                        0    1    0
  G     Carbohydrate metabolism and transport     43     3                                         2                                         0                                        0     3                                         1    0                                        0    2                                        0                                        0                                        0    0    0
  H     Coenzyme metabolis                        77     5                                         2                                         2                                        1     5                                         1    0                                        3    1                                        0                                        0                                        0    1    2
  I     Lipid metabolism                          42     4                                         2                                         1                                        0     4                                         1    1                                        1    1                                        4                                        1                                        0    0    0
  J     Tranlsation                               122    7                                         6                                         1                                        2     7                                         3    2                                        2    0                                        6                                        5                                        1    0    0
  K     Transcription                             33     3                                         2                                         2                                        1     4                                         0    0                                        1    1                                        2                                        4                                        0    0    0
  L     Replication and repair                    88     9                                         7                                         1                                        2     4                                         4    3                                        1    2                                        6                                        2                                        1    1    0
  M     Cell wall/membrane/envelop biogenesis     98     16                                        8                                         4                                        5     20[\*](#t003fn003){ref-type="table-fn"}   3    3                                        4    8[\*](#t003fn003){ref-type="table-fn"}   5                                        5                                        1    1    3
  N     Cell motility                             52     5                                         2                                         5                                        2     7                                         1    1                                        2    0                                        3                                        5                                        3    0    0
  O     Post-translational modification           63     3                                         5                                         3                                        0     9                                         2    3                                        3    2                                        4                                        3                                        1    1    1
  P     Inorganic ion transport and metabolism    62     10                                        4                                         1                                        2     6                                         2    1                                        0    4                                        1                                        3                                        1    1    0
  Q     Secondary Structure                       15     2                                         0                                         0                                        0     1                                         0    0                                        1    0                                        1                                        0                                        0    0    0
  R     General Functional Prediction only        131    17                                        10                                        3                                        3     7                                         4    3                                        4    2                                        5                                        2                                        1    0    1
  S     Function Unknown                          72     7                                         1                                         1                                        0     8                                         4    2                                        0    0                                        5                                        4                                        0    0    2
  T     Signal Transduction                       25     5                                         2                                         5[\*](#t003fn003){ref-type="table-fn"}   1     5                                         0    1                                        1    1                                        3                                        3                                        2    0    0
  U     Intracellular trafficking and secretion   51     1                                         1                                         2                                        2     2                                         0    2                                        0    2                                        2                                        1                                        0    1    0
  Z     Cytoskeleton                              1      0                                         0                                         0                                        0     0                                         0    0                                        0    0                                        0                                        0                                        0    0    0
  OMP   Outer membrane protein                    46     18[\*](#t003fn003){ref-type="table-fn"}   11[\*](#t003fn003){ref-type="table-fn"}   3                                        4     14[\*](#t003fn003){ref-type="table-fn"}   3    5[\*](#t003fn003){ref-type="table-fn"}   3    4                                        8[\*](#t003fn003){ref-type="table-fn"}   8[\*](#t003fn003){ref-type="table-fn"}   3    2    6[\*](#t003fn003){ref-type="table-fn"}
  N/A                                             355    31                                        16                                        9                                        6     24                                        6    12                                       7    3                                        9                                        12                                       4    3    5
  Sum                                             1607   148                                       78                                        44                                       36    107                                       40   38                                       39   32                                       62                                       53                                       18   12   16

a Strain used as reference strain for mapping.

b K15 and K17 were counted together because we cannot assign strain specific substitutions by comparison of two strains.

\* Counts were tested by Fischer\'s exact test, P \< 0.01

Genes not assigned to a COG category were also analyzed. Genes annotated as encoding OMPs \[[@pone.0127197.ref034]\] were the most frequently enriched with the amino acid changing mutations among the strains after transmission, as reported \[[@pone.0127197.ref027]\]. These included *alpAB*, *hofABDEF*, *horD*, *hopADFGINQZ*, *homBD*, *babAB* and other hypothetical OMPs (**[Table 4](#pone.0127197.t004){ref-type="table"} and [S6 Table](#pone.0127197.s006){ref-type="supplementary-material"}**).

10.1371/journal.pone.0127197.t004

###### Select genes with an amino-acid substitution in *H*. *pylori* from children.
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  Group                      Comment                              Gene
  -------------------------- ------------------------------------ --------------------------------------------------------
  Virulence-related          cagPAI (cag pathogenicity island)    *cagA*, *cagC*, *cagV*, *cagW*, *cagY*, *cag5*
                             vacA homologs                        *vacA*, vacA paralog, vacA paralog
                             Helicobacter cysteine-rich protein   *hcpD*, *hcpX*
                             Proteases                            *htrA*, collagenase
                             Type IV secretion system             *virB2*, *comH*
                             Lewis antigen mimicry                *fucT*
                             Others                               *tnfα* (Tumor Necrosis Factor alpha-inducing protein),
                                                                  *ggt* (gamma-glutamyltranspeptidase)
  Outer membrane protein     Hop family                           *hopADFGINQZ*
                             Hof family                           *hofABDEF*
                             Others                               *alpAB*, *homBD*, *babAB*, *horD*
  Restriction-modification   Type I                               Restriction gene
                             Type IIG                             
                             Type III                             Restriction gene, Modification gene

Various known virulence factors were identified among them (**[Table 4](#pone.0127197.t004){ref-type="table"}**). The *cagACTWY* genes reside on the cag pathogenicity island \[[@pone.0127197.ref035]\]; *vacA* is known to cause vacuolation in host cells \[[@pone.0127197.ref036]\] and *virB2* and *comH* are included in Type IV secretion systems, which are used for DNA import from the surrounding environment \[[@pone.0127197.ref037]\]. Cysteine-rich proteins \[[@pone.0127197.ref038]\] and HtrA protease \[[@pone.0127197.ref039]\] are involved in host interaction. The *tnfα* gene induces tumor necrosis factor alpha in the host \[[@pone.0127197.ref040]\] and gamma-glutamyltranspeptidase promotes pathogenesis \[[@pone.0127197.ref041]--[@pone.0127197.ref043]\]. The *fucT* gene is used for Lewis antigen mimicry and is important for immunity avoidance \[[@pone.0127197.ref044]\]. We also found amino acid substitutions in several restriction-modification genes (**[Table 4](#pone.0127197.t004){ref-type="table"}**).

Common and different patterns of evolution in familial transmission {#sec007}
-------------------------------------------------------------------

We focused on three families involving children to gain insight into the steps of *H*. *pylori* adaptation to a human child host (**[Table 5](#pone.0127197.t005){ref-type="table"}**and **[S6 Table](#pone.0127197.s006){ref-type="supplementary-material"}**). We emphasize that each lineage has a unique pattern of amino acid changing mutations but they all showed a change in *cag* and other virulence-related genes.

10.1371/journal.pone.0127197.t005

###### Genes with non-synonymous mutations and annotations in *H*. *pylori* from children.
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  Family   Strain   Group/ COG category        Gene         Annotation                                                                 Locus tag of F30 ortholog
  -------- -------- -------------------------- ------------ -------------------------------------------------------------------------- ---------------------------
  K-5      K23      Virulence-related          *cagA*       Cag pathogenicity island protein                                           HPF30_0779
                    Virulence-related          *cagC*       Cag pathogenicity island protein                                           HPF30_0780
                    Outer membrane protein     *hopQ*       Outer membrane protein                                                     HPF30_0214
                    Outer membrane protein     *hopI*       Outer membrane protein HopI                                                HPF30_0234
                    Outer membrane protein     *alpB*       Outer membrane protein AlpB                                                HPF30_0426
                    J                          *sfhB*       Pseudouridine synthase                                                     HPF30_0951
                    M                          *ftsI*       Cell division protein                                                      HPF30_1449
                    NT                                      Methyl-accepting chemotaxis protein                                        HPF30_0728
                    NT                         *mcpB*       Methyl-accepting chemotaxis protein                                        HPF30_1183
                    NO                         *flgA*       Flagellar basal body P-ring biosynthesis protein FlgA                      HPF30_1345
                    P                          *fecA_2*     Iron dicitrate transport protein                                           HPF30_0524
                    R                          *rny*        Ribonuclease Y                                                             HPF30_0573
                                               *hpaA*       Flagellar sheath adhesin HpaA                                              HPF30_0534
           K24      Virulence-related          *comH*       Periplasmic competence protein                                             HPF30_1399
                    Outer membrane protein     *alpB*       Outer membrane protein AlpB                                                HPF30_0426
                    Outer membrane protein     *hopN-2*     Outer membrane protein HopN2                                               HPF30_1068
                    V                          *hsdR_2*     Type I restriction enzyme R protein                                        HPF30_0485
                    MU                         *hefA*       Outer membrane protein HefA                                                HPF30_0721
                    P                                       Catalase-related peroxidase                                                HPF30_0836
                    H                          *hemA*       Glutamyl-tRNA reductase                                                    HPF30_1056
                    F                          *purB*       Adenylosuccinate lyase                                                     HPF30_0276
           K25      Outer membrane protein     *babB*       Outer membrane protein                                                     HPF30_0154
                    Outer membrane protein     *hopL*       Outer membrane protein HopL                                                HPF30_0233
                    Outer membrane protein     *alpB*       Outer membrane protein AlpB                                                HPF30_0426
                    Outer membrane protein     *alpA*       Outer membrane protein AlpA                                                HPF30_0427
                    Outer membrane protein     *babA*       Outer membrane protein BabA                                                HPF30_0441
                    Outer membrane protein     *hopF*       Outer membrane protein HopF                                                HPF30_1043
                    Virulence-related          *cagC*       Cag pathogenicity island protein                                           HPF30_0780
                    O                          *pcm*        Protein-beta-aspartate methyltransferase                                   HPF30_0297
                    M                          *cfa*        Cyclopropane fatty acid synthase                                           HPF30_0349
                    C                          *atpB*       F-ATPase subunit 6                                                         HPF30_0502
                    H                          *mogA*       Molybdenum cofactor biosynthesis protein                                   HPF30_0532
                    M                                       Putative outer membrane protein                                            HPF30_0673
                    C                          *ppa*        Pyrophosphate phospho-hydrolase                                            HPF30_0706
                    H                          *hemA*       Glutamyl-tRNA reductase                                                    HPF30_1056
                    M                          *rfaJ-1*     Putative lipopolysaccharide biosynthesis protein                           HPF30_1136
                    R                          *engB*       Probable GTP-binding protein EngB                                          HPF30_1459
                                               *hpaA*       Flagellar sheath adhesin HpaA                                              HPF30_0534
  K-2      K36      Outer membrane protein     *hopQ*       Outer membrane protein                                                     HPF30_0214
                    Outer membrane protein     *alpA*       Outer membrane protein AlpA                                                HPF30_0427
                    Outer membrane protein     *hopA*       Outer membrane protein HopA                                                HPF30_1066
                    Virulence-related          *fucT*       Alpha-(1,3)-fucosyltransferase                                             HPF30_0677
                    Virulence-related                       Tumor necrosis factor alpha-inducing protein                               HPF30_0731
                    Virulence-related          *cagA*       Cag pathogenicity island protein                                           HPF30_0779
                    Restriction-modification   *res-2*      Type III restriction enzyme R protein                                      HPF30_0033
                    O                          *groS*       Protein Cpn10                                                              HPF30_0009
                    H                          *pnuC*       Nicotinamide mononucleotide transporter                                    HPF30_0110
                    K                          *cobB*       Regulatory protein SIR2 homolog                                            HPF30_0138
                    V                                       ABC-transporter, ATP-binding domain                                        HPF30_0187
                    C                          *bisC-frg*   Biotin sulfoxide reductase BisC                                            HPF30_0341
                    M                          *capJ*       Type 1 capsular polysaccharide biosynthesis protein J                      HPF30_0354
                    R                          *hypA*       Probable hydrogenase nickel incorporation protein HypA                     HPF30_0464
                    O                          *tig*        PPIase                                                                     HPF30_0536
                    TK                         *spoT*       Penta-phosphate guanosine-3\'-pyrophosphohydrolase                         HPF30_0555
                    FE                         *prsA*       Phosphoribosyl pyrophosphate synthase                                      HPF30_0592
                    NT                                      Methyl-accepting chemotaxis protein                                        HPF30_0728
                    H                          *bioF*       8-amino-7-oxononanoate synthase                                            HPF30_0729
                    M                          *pldA*       Phospholipase A1                                                           HPF30_0822
                    N                          *fliG*       Flagellar motor switch protein G                                           HPF30_0946
                    I                          *dxr*        2-C-methyl-D-erythritol 4-phosphate synthase                               HPF30_1079
                    M                          *rfaJ-2*     Putative lipopolysaccharide biosynthesis protein                           HPF30_1087
                    M                          *rfaJ-1*     Putative lipopolysaccharide biosynthesis protein                           HPF30_1136
                    P                                       C(4)-dicarboxylates and tricarboxylates/succinate antiporter               HPF30_1152
                    NT                         *tlpA*       Methyl-accepting chemotaxis protein                                        HPF30_1179
                    NT                         *mcpB*       Methyl-accepting chemotaxis protein                                        HPF30_1183
                    NT                                      Methyl-accepting chemotaxis transducer                                     HPF30_1218
                    L                          *topA*       DNA topoisomerase I                                                        HPF30_1195
                    U                          *comB1*      ComB8 competence protein                                                   HPF30_1259
                    U                          *comB6*      NADH-ubiquinone oxidoreductase subunit                                     HPF30_1260
                    F                                       Putative endonuclease, split and separated by inversion, N-terminus part   HPF30_1272
                    J                          *rpsB*       30S ribosomal protein S2                                                   HPF30_1429
           K37      Outer membrane protein     *hopQ*       Outer membrane protein                                                     HPF30_0214
                    Outer membrane protein     *hopL*       Outer membrane protein HopL                                                HPF30_0233
                    Outer membrane protein     *hofG*       Putative outer membrane protein                                            HPF30_0425
                    Outer membrane protein     *alpB*       Outer membrane protein AlpB                                                HPF30_0426
                    Virulence-related          *cagA*       Cag pathogenicity island protein                                           HPF30_0779
                    Restriction-modification   *res-2*      Type III restriction enzyme R protein                                      HPF30_0033
                    Restriction-modification                Type IIG restriction-modification enzyme                                   HPF30_0661
                    F                          *pyrF*       Orotidine 5\'-phosphate decarboxylase                                      HPF30_0005
                    M                          *tonB*       Siderophore-mediated iron transport protein                                HPF30_0059
                    J                          *rpsK*       30S ribosomal protein S11                                                  HPF30_0105
                    K                          *rpoB*       DNA-directed RNA polymerase subunit beta/beta                              HPF30_0196
                    P                                       Carbonic anhydrase                                                         HPF30_0205
                    M                                       Putative lipopolysaccharide biosynthesis protein                           HPF30_0284
                    C                          *bisC-frg*   Biotin sulfoxide reductase BisC                                            HPF30_0341
                    C                          *ackA*       Acetokinase                                                                HPF30_0435
                    P                                       Iron(III) dicitrate transport protein                                      HPF30_0645
                    L                          *rnhA*       Ribonuclease H                                                             HPF30_0667
                    V                          *hefC*       Cytoplasmic pump protein of the hefABC efflux system HefC                  HPF30_0719
                    MU                         *hefA*       Outer membrane protein HefA                                                HPF30_0721
                    M                          *pbp-1a*     Penicillin-binding protein 1A                                              HPF30_0730
                    NU                         *flhA*       Flagellar biosynthesis protein FlhA                                        HPF30_0891
                    J                          *infB*       Translation initiation factor IF-2                                         HPF30_0898
                    D                          *minC*       Septum formation inhibitor                                                 HPF30_0903
                    L                          *ruvB*       Holliday junction ATP-dependent DNA helicase RuvB                          HPF30_0909
                    R                                       Oligopeptide permease integral membrane protein                            HPF30_1044
                    NT                         *mcpB*       Methyl-accepting chemotaxis protein                                        HPF30_1183
                    C                                       Ferrodoxin-like protein                                                    HPF30_1378
  K-3      K28      Outer membrane protein     *hopQ*       Outer membrane protein                                                     HPF30_0214
                    Outer membrane protein     *alpB*       Outer membrane protein AlpB                                                HPF30_0426
                    Outer membrane protein     *hofE*       Outer membrane protein HofE                                                HPF30_0548
                    Outer membrane protein     *hofB*       Outer membrane protein HofB                                                HPF30_0932
                    Outer membrane protein     *hopN-2*     Outer membrane protein HopN2                                               HPF30_1068
                    Virulence-related          *cagV*       Cag pathogenicity island protein                                           HPF30_0794
                    Virulence-related          *cagW*       Cag pathogenicity island protein                                           HPF30_0795
                    Virulence-related          *cagY*       Cag pathogenicity island protein                                           HPF30_0797
                    Virulence-related          *cag5*       Cag pathogenicity island protein                                           HPF30_0800
                    Virulence-related          *vacA*       Vacuolating cytotoxin A                                                    HPF30_0448
                    Restriction-modification   *mod-4*      Putative type III restriction enzyme M protein                             HPF30_1273
                    Restriction-modification                Type I restriction enzyme R protein                                        HPF30_0858
                    Restriction-modification   *hsdR_3*     Type I restriction enzyme R protein                                        HPF30_1407
                    L                          *dnaG*       DNA primase                                                                HPF30_0010
                    R                                       Lipid A phosphoethanolamine transferase                                    HPF30_0020
                    O                          *clpX*       ATP-dependent Clp protease ATP-binding subunit ClpX                        HPF30_0030
                    I                                       Isoprenyl transferase                                                      HPF30_0175
                    J                          *valS*       Valyl-tRNA synthetase                                                      HPF30_0237
                    E                          *nifS_2*     NifS-like protein                                                          HPF30_0338
                    S                          *truD*       tRNA-uridine isomerase D                                                   HPF30_0415
                    C                          *ackA*       Acetokinase                                                                HPF30_0435
                    S                                       Uncharacterized protein                                                    HPF30_0472
                    M                          *waaE*       Bifunctional protein HldE                                                  HPF30_0475
                    M                          *amiA*       N-acetylmuramoyl-L-alanine amidase                                         HPF30_0558
                    R                          *rny*        Ribonuclease Y                                                             HPF30_0573
                    L                          *uvrA*       Excinuclease ABC subunit A                                                 HPF30_0629
                    M                                       Putative outer membrane protein                                            HPF30_0673
                    P                          *kefB*       Glutathione-regulated potassium-efflux system protein                      HPF30_0851
                    O                          *htrA*       Protease DO                                                                HPF30_0869
                    J                          *infB*       Translation initiation factor IF-2                                         HPF30_0898
                    NT                         *tlpA*       Methyl-accepting chemotaxis protein                                        HPF30_1179
                    O                          *clpA*       ATP-dependent C1p protease                                                 HPF30_1264
                                                            Response regulator                                                         HPF30_0871

### (i) Family K-2: K36 and K37 {#sec008}

K36 had specific nonsynonymous nucleotide substitutions in five motility genes, five signal transduction genes, *cagA*, *tnfα*, *hcpD*, *fucT*, *rfaJ-1/2*, and one Type III R (restriction) gene. K37 had these types of mutations in *cagA*, *hcpD*, the RNA polymerase subunit gene (*rpoB*) and two restriction-modification genes (Type IIG and Type III R) as well as four OMP genes.

### (ii) Family K-3: K28 {#sec009}

Among the 49 genes with at least one nonsynonymous nucleotide substitution specific to the child strain, there are four *cag* genes (*cagV*, *cagW*, *cagY* and *cag5*), *vacA*, *htrA*, five OMP genes, three restriction-modification genes (two Type I R and one Type III M) and *clpX/clpP* protease genes (**[Table 5](#pone.0127197.t005){ref-type="table"}**).

### (iii) Family K-5: K23, K24 and K25 {#sec010}

Among the three strains isolated from the three children in family K-5, K24 had the fewest (*n* = 12) genes with an amino acid change, among which are a virulence-related gene (*comH*), a restriction-modification gene (Type I R), *purB* for nucleotide metabolism, a peroxidase gene and a heme biosynthesis gene. K23 had nonsynonymous substitutions in *cagAC* genes, four genes related to motility and chemotaxis and two genes related to signal transduction. K25 had nonsynonymous mutations in *cagC*, three genes (*ppa*, *rfaJ-1* and *cfa*) related to lipids, *atpB* for membrane ATP synthase and *pcm* for protein repair.

Discussion {#sec011}
==========

*H*. *pylori* is known for sequence diversity between different strains, but strains from the same lineage can be difficult to distinguish by the standard MLST analysis using only seven genes. We undertook whole genome sequencing and distinguished the strain-specific nucleotide substitutions for isolates with the same or very similar MLST sequence type from the same family. On the basis of sequence difference, we revealed the likely pathway of evolution between these strains in some cases. Furthermore, after analyzing the nonsynonymous mutations, we suggested the strategy of *H*. *pylori* evolution during infection.

Following the construction of phylogenetic trees based on SNPs in the whole genome sequences. We inferred the direction of transfer between family members and other details (**[Fig 1](#pone.0127197.g001){ref-type="fig"}**). However, a recent study revealed a broad diversity in genome sequences in strains isolated from one specimen from one person \[[@pone.0127197.ref045]\]. The diversity represented in the above phylogenetic trees might well be accounted for by the diversity of lineages within an individual. In **[Fig 1B](#pone.0127197.g001){ref-type="fig"}(ii)**, for example, the mother might have transferred one lineage (the ancestor of K36) to one child and transferred another, well diversified strain (the ancestor of K37) to the other child. In order to clarify transmission pathways accurately, we need genome sequences of multiple strains from one host.

The mutation rate was calculated on the basis of strain-specific SNVs. Most of the value was included with the mutation rate range in earlier calculations from whole genome information \[[@pone.0127197.ref026], [@pone.0127197.ref031], [@pone.0127197.ref032]\] and only the K24 strain was a little below the range (**[S4 Table](#pone.0127197.s004){ref-type="supplementary-material"}**). This difference might reflect the origin of *H*. *pylori* strains. Earlier work using whole genome sequences was with strains from South Africa \[[@pone.0127197.ref026]\], whereas strains isolated in Japan were used in the present study. Another possibility is recombination between lineages \[[@pone.0127197.ref045]\]. By contrast, work using 78 genes for analysis gave a much lower value for the mutation rate, using strains derived from USA, UK, Colombia, the Netherlands and South Korea \[[@pone.0127197.ref032]\]. This result might be related to the large difference in sequence diversity among genes: indeed, different genes can evolve at very different rates \[[@pone.0127197.ref004], [@pone.0127197.ref005]\]. More analysis of whole genomes and individual genes in strains from various regions is required to fully understand the apparent variation of mutation rate.

Genes with an amino acid change might provide insight into the adaptation process. Many of these genes are related to the surface structure of the *H*. *pylori* cell, including OMP genes, lipoprotein-related genes and *fucT*, as found in other work on intrafamilial transmission and intrahost transmission \[[@pone.0127197.ref027], [@pone.0127197.ref031]\]. *H*. *pylori* can attach to human gastric epithelial cells through various kinds of adhesion factors, including BabA (HopS), BabB, SabA (HopP), SabB, AlpA and AlpB. Protein BabA is one of the major adhesion molecules associated with severe pathogenesis in *H*. *pylori* infection, although *babA* expression was reported to disappear by six months after infection of Mongolian gerbils with nucleotide changes introducing a stop codon of the gene \[[@pone.0127197.ref046]\]. AlpA and AlpB were shown to contribute to laminin binding of *H*. *pylori* and to induction of inflammatory changes of gastric mucosa \[[@pone.0127197.ref047]\]. HopQ might be important in initial colonization and long-term persistence of *H*. *pylori* in the stomach by modulating the adherence to gastric epithelial cells \[[@pone.0127197.ref048]\]. Two different alleles of *hopQ* were shown to be associated significantly with the positivity of other virulence genes, including *cagA* and *vacA* \[[@pone.0127197.ref049], [@pone.0127197.ref050]\].

An unexpected finding was the occurrence of amino acid substitutions in many virulence genes other than OMP genes and other surface-related genes. The genes of *vacA* and *cagA* are well known as important virulence-related genes of *H*. *pylori*. Mutations in these virulence genes were detected in *H*. *pylori* isolates of one or two family member(s) in each family but not, in general, in the isolates of all members of a family. One interesting possibility responsible for this observation is that these changes in virulence factors are related to adaptation to children in intrafamilial transmission. A related finding is that CagA is the most reactive antigen recognized by *H*. *pylori*-positive sera from children \[[@pone.0127197.ref051]\].

Amino acid changes in restriction-modification systems were detected in the three families involving children (see the last section in [Results](#sec002){ref-type="sec"}). A restriction-modification system consists of DNA methyltransferase, a modification enzyme, and a restriction endonuclease. DNA methyltransferase transfers a methyl group to a specific DNA sequence in the genome, which likely affects global gene expression among others. The restriction enzyme destroys DNA lacking such specific methylation resulting in genetic isolation. Recent work demonstrated the restriction-modification systems in *H*. *pylori* frequently change their presence/absence, sequence specificity and expression to remodel the methylome \[[@pone.0127197.ref007], [@pone.0127197.ref010]\]. The mutations mentioned above could be related to adaptation to a new host through such epigenetics-driven adaptive evolution \[[@pone.0127197.ref052]\]. Substitution of target recognition domains of restriction-modification systems underlying drastic changes in recognition sequence \[[@pone.0127197.ref011], [@pone.0127197.ref012]\], however, cannot be detected, in principle, by the present method based on mapping a genome sequence and SNP analysis.

Mutations were found in earlier work comparing whole genome sequences of closely related strains, especially in OMP genes, which is consistent with the results presented here \[[@pone.0127197.ref027], [@pone.0127197.ref028], [@pone.0127197.ref031], [@pone.0127197.ref053]\]. Comparison of whole genome sequences of *H*. *pylori* isolated from grandfather, son and grandson of a family in England found amino acid changes in OMP genes \[[@pone.0127197.ref028]\]. Substitution mutations in OMP genes were found in inter-spouse transmission in Australia \[[@pone.0127197.ref027]\]. A mutation burst was found during the acute phase of *H*. *pylori* infection leading to mutational changes in OMPs and *cag*-related genes in humans and primates \[[@pone.0127197.ref053]\]. These results are consistent with the present study and we additionally found mutations commonly observed in isolates from children in two categories; i.e. virulence factors other than *cag*-related and restriction-modification enzymes. This difference might be caused because of isolation in young children, compared to isolation from adults in other studies, but we cannot exclude the possibility it is caused by differences in environment.

We assumed that the individual human hosts have driven the bacterial mutations in the above genes. Our procedures involved culturing the bacteria *ex vivo* as in almost all the works on bacterial variations. Have the *ex vivo* steps, as opposed to *in vivo* steps, induced or selected the mutations we observed here? We think that most of the strain-specific nonsynonymous substitutions were generated *in vivo* for the following reasons. First, many of the genes with those mutations also show rapid sequence changes in phylogeny giving long branches in their phylogenetic tree \[[@pone.0127197.ref004], [@pone.0127197.ref005]\]. A simplest interpretation is the host adaptation through a nonsynonymous mutation is repeated for many generations to result in the rapid evolutionary rate. Second, comparable mutation rates per year were obtained in this and other studies based on strain culture *ex vivo* (**[Table 2](#pone.0127197.t002){ref-type="table"}**). This indicates that the number of mutations is approximately proportional to the years within a human body. This cannot be expected only through mutagenesis and selection *in vivo*. Third, the strain-specific nonsynonymous mutations are unique to each of the strains. For example, K23, but no other strains, carries such mutations in multiple *cag* genes and several motility/chemotaxis-related genes among 14 genes with annotation (**[Table 5](#pone.0127197.t005){ref-type="table"}**). Many strains carry those strain-specific nonsynonymous mutations in OMP genes, but the OMP repertoire is quite diverse among the strains. The difference is not likely a result of mutagenesis and/or selection during *ex vivo* culture, during which we used a medium of the same recipe, especially, the same batch of horse serum (see [Materials and methods](#sec012){ref-type="sec"}). From these considerations, it is, at present, natural to interpret that most of these strain-specific non-synonymous mutations were introduced during the long-term (years of) growth in individual human stomachs although we cannot exclude some contribution of *ex vivo* growth.

In conclusion, our whole genome decoding of *H*. *pylori* strains from family members including children suggested adaptation of these bacteria to a new human host through mutations in virulence-related genes and restriction-modification genes in addition to OMP genes.

Materials and Methods {#sec012}
=====================

Ethics statement {#sec013}
----------------

This study was undertaken with approval from the Ethics Committees of Kyorin University, Tokyo (No. 537) and Sapporo Kosei General Hospital (H24-104). Written informed consent was obtained from the patients (5 years old or older) and also from their parents when the patients are minor.

Strains {#sec014}
-------

In all, 19 *H*. *pylori* strains were obtained from five families during April 2011---December 2012 in Sapporo Kosei General Hospital, Sapporo, Hokkaido, Japan. A single colony was isolated and subcultured on Brucella medium supplemented with 1.5% (w/v) agar and 7% (v/v) horse serum (BHS medium) under microaerobic conditions. The same batch of horse serum was used for the culture to minimize possible variation between cultures. Typing of strains was done initially by seven-gene MLST for all five families \[[@pone.0127197.ref029]\].

Genome sequencing and mapping {#sec015}
-----------------------------

After incubation for 48 h under microaerobic conditions at 37°C on BHS medium, the culture of *H*. *pylori* (about 5×10^8^ colony-forming units) was collected. A Wizard Genomic DNA purification kit (Promega, Madison, WI, USA) was used according to the manufacturer's instructions to isolate genomic DNA. A DNA library for genome sequencing was constructed by Nextera XT (Illumina, CA, USA) and sequenced by HiSeq2500 (Illumina, CA, USA).

About 1.4×10^6^ reads (\~×200 coverage) with a length of 100 bp in the form of paired ends were selected from each read data (DRA accession no. 002504) and mapped against the genome sequence of *H*. *pylori* strain F30 (accession no. NC_017365) by BWA \[[@pone.0127197.ref054]\]. Nucleotide substitutions were detected by SAMtools software \[[@pone.0127197.ref055]\] without misalignment filtering to avoid pseudo-negative detection. Lists of nucleotide substitutions were compared by customized Perl scripts for calculation of the distance between strain pairs and for detection of strain-specific nucleotide substitutions. Nucleotide sites with coverage of more than five reads for all the members of a family with the same or very similar MLST sequence type were used for the detection of nucleotide substitution. Classification of nucleotide substitution to nonsynonymous, synonymous or substitutions at noncoding regions were done according to the gene annotation of *H*. *pylori* F30 \[[@pone.0127197.ref004]\]. For the calculation of strain-specific substitutions, the substitutions in strains K17 and K15 in family K-1 were counted together because the family has only two strains with the same MLST sequence type and it is not possible to assign substitutions to either of the strains.

The significance of differences between distances among strains with the same or very similar sequence type was analyzed by generating a matrix assuming the same probability of nucleotide substitution accumulation for all strain pairs. Matrices were constructed 1×10^6^ times and the rank list of standard deviation was compared with the standard deviation of distances in the real data for calculation of the *P* value.

COG enrichment {#sec016}
--------------

COG of genes in the *H*. *pylori* F30 genome was annotated by rpsblast \[[@pone.0127197.ref056]\]. Genes with strain-specific nonsynonymous substitutions were counted and the significance of COG enrichment was tested by Fisher's exact test. A gene was counted only once even if it had more than two strain-specific nonsynonymous substitutions.
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